- Blueprint Medicines (NASDAQ:BPMC): Q3 GAAP EPS of -$1.93 beats by $0.26.
- Revenue of $9.14M (+730.9% Y/Y) beats by $6.29M.
- Press Release
Blueprint Medicines EPS beats by $0.26, beats on revenue
Recommended For You
More Trending News
About BPMC Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BPMC | - | - |
Blueprint Medicines Corporation |